Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?

Heart failure with preserved ejection fraction (HFpEF) comprises half of the heart failure population. A specific, but underdiagnosed, cause for HFpEF is transthyretin-derived (ATTR) amyloidosis. This article reviews the clinical characteristics of cardiac ATTR amyloidosis. The clinical suspicion of...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaassen, Sebastiaan HC, van Veldhuisen, Dirk J, Nienhuis, Hans LA, van den Berg, Maarten P, Hazenberg, Bouke PC, van der Meer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2020
Materias:
Cardiac Amyloidosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479537/
https://www.ncbi.nlm.nih.gov/pubmed/32944291
http://dx.doi.org/10.15420/cfr.2019.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479537/
https://www.ncbi.nlm.nih.gov/pubmed/32944291
http://dx.doi.org/10.15420/cfr.2019.16

Ejemplares similares